|
Drug
|
Dosage
|
Major Indications / Remarks
|
|
Acyclovir
|
30 mg/kg/d divided q 8 hr IV
administer over 1 hr
|
Herpes Simplex & Varicella.
increase dosing interval with <34 wk gest or with
significant renal / hepatic failure
|
|
Amikacin*
|
7.5 - 10 mg/kg per dose IV / IM
see
Gentamicin for
dosing schedule
|
Gram negative enteric bacteria
peak 20-30, trough 5-10 mcg/ml
|
|
Amphotericin B
|
test dose: 0.1 mg/kg
initial dose: 0.25 mg/kg
increment : 0.125 - 0.25 gm/kg/d
maintenance dose: 1 mg/kg/d qd or 1.5 mg/kg/d qod
|
Most systemic fungal infections & severe superficial
mycoses; Give over 4 to 6 hr. Decreases renal blood flow /
GFR; Monitor renal / hepatic status closely.
total dose: 15-30 mg/kg
|
|
Ampicillin
Mild - Moderate infection
Meningitis
|
200 mg/kg/d ÷ q 12 hr
IV or IM, q 8 hr ³ 1 week age
400 mg/kg/d ÷ q 8-12 hr
|
Group B streptococcus, enterococcus,
E coli, Listeria monocytogenes
|
|
Cephalothin
|
20 mg/kg q 6-8 hr IV / IM
|
Gram + cocci
|
|
Cefazolin
|
< 7 days: 20 mg/kg q 12 hr IV / IM
> 7 days: 20 mg/kg q 8 hr
|
Gram + cocci ; may cause false positive urine reducing
substance
|
|
Cefotaxime & Ceftazidime
|
50 mg/kg dose IV over 30 min.
|
Gest. age
|
Postnatal age
|
Interval (q)
|
|
< 29 wk
|
0 to 28 d
|
12 hr
|
|
> 28 d
|
8 hr
|
|
30 -36 wk
|
0 to 14 d
|
12 hr
|
|
> 14 d
|
8 hr
|
|
³ 37 wk
|
0 to 7 d
|
12 hr
|
|
> 7 d
|
8 hr
|
|
Cefotaxime:
Gram - enteric bacteria
penetrates well across BBB and good for use in meningitis
Ceftazidime:
Gram - , esp. Pseudomonas ; Consider two
antibiotics with positive Pseudomns. cultures
|
|
Ceftriaxone
|
50 - 75 mg/kg/dose IV/IM
<1.2 kg: <28 d:q 24 h; >28
d: q12 h
>1.2 kg: < 7 d: q 24 h; > 7
d: q12 h
|
Gram - bacteria and
gonococcal infection
|
|
Clindamycin
|
Preterm <1mo: 5 mg/kg q 8 h IV
Preterm >1mo: 5 mg/kg q 6 h
Full term: 5 - 10 mg/kg q 6 h
|
Gram + cocci and bacteroides
Psuedomembranous colitis most serious adverse effect
Æ bloody diarrhea, fever
|
|
Erythromycin
|
10-15 mg/kg q 8-12 hr. PO
|
Chlamydia and Mycoplasma
|
|
Gentamicin*
|
2.5 mg/kg/dose
|
Gest. age
|
Postnatal age
|
Interval (q)
|
|
< 28 wk
|
0 to 14 d
|
24 hr
|
|
14 to 28 d
|
18 hr
|
|
> 28 d
|
12 hr
|
|
29-34 wk
|
0 to 14 d
|
18 hr
|
|
> 14 d
|
12 hr
|
|
³ 37 wk
|
0 to 7 d
|
12 hr
|
|
> 7 d
|
8 hr
|
|
Gram negative aerobic bacilli;
Ototoxic effects synergistic with lasix. Need to monitor
serum levels:
Trough: < 2; Peak: 4 - 8 mg/L
For high trough levels, increasing dosing interval to
next higher level is usually sufficient - always recheck
levels again after adjusting dosage/interval
|
|
Isoniazid
|
10 mg/kg PO q d
|
Mycobacteria
|
|
Methicillin
&
Nafcillin
|
25 - 50 mg/kg/dose IV / IM
< 2 kg: < 7 d: q12 h; > 7
d: q 8 h
> 2 kg: < 7 d: q 8 h; > 7
d: q 6 h
|
Penicillinase-producing Staphylococcus aureus. Use
Nafcillin for renal dysfunction pts. Use the higher doses
for meningitis
|
|
Metronidazole
|
Loading dose: 15 mg/kg IV
Maintenance dose: 7.5 mg/kg IV q12 h
|
anaerobic infections; begin maintenance dose 48 h after
load in preterm infants & after 24 h in term infants
|
|
Oxacillin
|
25 mg/kg/dose IV / IM
< 7d: q 12 hr. > 7 d: q 6-8 hr
|
Penicillinase-producing Staphylococcus Aureus
|
|
Mezlocillin & Piperacillin
|
50 - 100 mg/kg/dose IV / IM
See Methicillin for dosing schedule
|
Pseudomonas, Gr B Strep, most Klebsiella
pneumoniae and Serratia marcescens
|
|
Penicillins
|
|
Non-producing Penicillinase organisms
|
|
Pen G: Meningitis
|
75,000 - 100,000 IU/kg/dose IV
|
See Methicillin for dosing schedule
|
|
Pen G: Sepsis
|
25,000 - 50,000 IU/kg/dose
See Methicillin for dosing schedule
|
Treatment of susceptible organisms:
streptococci , cong. syphilis, gonococci
For group B strep sepsis: 200,000 IU/kg/d
and 400,000 IU/kg/d with meningitis
|
|
Benzathine
|
50,000 units/kg one dose IM
50,000 U/kg IM q wk x 3 doses
|
Syphilis (No clinical findings and only if
follow-up cannot be ensured)
Syphilis > 1 yr. in mother
|
|
Procaine
|
50,000 units/kg q day IM
|
Syphilis
|
|
Ribavirin
|
Dilute 6 gm in 300 ml sterile water. Administer by
aerosol over 12 - 18 hr
daily for 3 - 7 days
|
Respiratory syncytial virus (severe herpes). Most
effective if begun early in course of illness. May worsen
respiratory distress
|
|
Rifampin
|
Children:
5 - 10 mg/kg PO/IV q 12 hr
|
Mycobacteria; causes red discoloration of body
secretions.
|
|
Ticarcillin
|
75 mg/kg/dose IV
< 1.2 kg: 0-4 wk: q 12 hr
< 2 kg: < 7 d q 12 h; > 7 d
q 8 h
> 2 kg: < 7 d q 8 h; > 7 d
q 6 h
|
Pseudomonas
may cause decreased platelet aggregation, bleeding
diathesis, hypernatremia, hypocalcemia, increased AST
|
|
Tobramycin*
|
2.5 mg/kg dose
See
Gentamicin for
dosing schedule
|
Aerobic gram-negative bacilli (e.g., E coli,
Pseudomonas, Klebsiella)
Need to monitor levels
Trough: < 2 mg/L. Peak: 5 - 10 mg/L
|
|
Vancomycin*
|
10 mg/kg per dose IV, give
by syringe pump over 60 min.
< 1 kg: < 7 d: q 24 h; > 7
d: q 18 h
1-2 kg: < 7 d: q 18 h; > 7 d:
q 12 h
>2 kg: <7 d: q 12 h; > 7
d: q 8 h
|
Methicillin-resistant staphylococci (e.g., S
aureus and S epidermidis) and
penicillin-resistant pneumococci. Note: Red man
syndrome results from rapid IV infusion.
Need to monitor serum levels
Trough: 5-10 mg/L; Peak: 25 - 40 mg/L
Give 15 mg/kg/dose if CNS infection
|
Young TE, Mangum OB. Neofax A manual of drugs used in neonatal
care. Sixth edition, Columbus, Ohio; Ross Laboratories, 1993.
Johnson KB. The Harriet Lane Handbook. 13th edition. Mosby - Year
Book, Inc., St Louis, MO, 1993
Brown & Campoli-Richards, 1989; (4) Beretz & Tato, 1988;
and (5) Remington & Klein, 1990.